CCKBR and peripheral neuropathy: In that model, preventive treatment with the CCK2R antagonists, proglumide (a non-specific CCK2R antagonist) or Ly225910 (a selective CCK2R antagonist), prevented the painful symptoms of vincristine-induced peripheral neuropathy, but only Ly225910 alleviated the nerve injuries induced by the anticancer agent.